低水平光疗对干眼疾病患者的效果
Antoinette Antwi1, Alexander W Schill1, Rachel Redfern1
1University of Houston College of Optometry, Houston, Texas, USA.
概括
低水平光疗 (LLLT) 在早期治疗阶段显著改善了干眼症状和症状,包括膜质量和眼睛舒适度. 这表明LLLT是一种有效的独立治疗方法,用于治疗干眼疾病.
科学领域:
- 眼科医生 眼科 眼科
- 生物医学工程 生物医学工程
背景情况:
- 干眼病影响着相当一部分人口,影响生活质量.
- 低水平光疗 (LLLT) 或光生物调制是干眼的新兴治疗方式.
- 有限的研究存在于LLLT作为独立干眼治疗.
研究的目的:
- 评估LLLT作为轻度至中度眼睛干燥的独立治疗方法的疗效.
- 评估LLLT对干眼的迹象和症状的影响.
主要方法:
- 一项三次访问的研究,涉及轻度至中度干眼的参与者.
- 参与者每次接受633nmLLLT,每次访问时间为15分钟.
- 关键的临床指标包括撕裂时间,撕裂半径高度,梅博米腺损失,OSDI得分和眼温度.
主要成果:
- 通过LLLT治疗,眼破裂时间,眼半径高度和眼膜脂质层厚度显著改善.
- 观察到眼部表面疾病指数 (OSDI) 得分显著降低,以及施尔默测试结果的改善.
- 在角膜光素染色或梅博米腺损失方面没有发现显著的变化.
结论:
- 在初始治疗期间,LLLT在改善干眼的迹象和症状方面表现出显著的有效性.
- 这些发现支持LLLT作为一种可行的独立治疗方法来治疗干眼疾病的潜力.
相关概念视频
01:23Ophthalmic Drug Delivery Systems
Ophthalmic drug delivery faces major limitations due to poor absorption across the corneal membrane. This process is primarily driven by diffusion and is influenced by two main factors: the physicochemical properties of the drug and tear drainage. Most ophthalmic drugs, such as pilocarpine, epinephrine, atropine, and local anesthetics, are weak bases. They are typically formulated at an acidic pH to enhance chemical stability. However, this leads to high ionization, reducing their ability to...
01:22Microbiome of the Eye
The human eye has a specialized microbiota that reflects its unique anatomical and immunological environment. This low-biomass microbial community predominantly colonizes the conjunctiva and eyelid margins, playing a vital role in ocular surface homeostasis and defense. Despite its proximity to the richly colonized facial skin, the ocular surface maintains a distinct microbial profile due to continuous mechanical and biochemical defense mechanisms.The conjunctival surface hosts fewer microbial...